Current Treatment Options in Oncology

Papers
(The H4-Index of Current Treatment Options in Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic89
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer65
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead65
Role of Metastasis-Directed Therapy in Genitourinary Cancers64
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)62
An Update on Temporal Bone Paragangliomas53
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies48
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer47
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma46
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect42
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia42
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes40
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T37
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?36
Approach to Localized Squamous Cell Cancer of the Esophagus35
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?34
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer33
The Role of Nursing in the Delivery of Cardio-Oncology33
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma33
Small Cell Lung Cancer—An Update on Chemotherapy Resistance29
Management of Fatigue in Patients with Advanced Cancer28
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers28
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer27
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements25
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?24
Regorafenib for the Treatment of Sarcoma24
Advances in Targeted Therapy for Metastatic Prostate Cancer24
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management24
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer24
0.047996044158936